BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9301793)

  • 1. [The latest problems of surgery for cancer of the esophagus].
    Nishihira T; Mori S; Sekine Y
    Rinsho Kyobu Geka; 1987; 7(5):419-24. PubMed ID: 9301793
    [No Abstract]   [Full Text] [Related]  

  • 2. [Squamous cell cancer of the esophagus. Treatment concept at the National Cancer Center in Tokyo].
    Watanabe H
    Chirurg; 1992 Sep; 63(9):689-92. PubMed ID: 1395873
    [No Abstract]   [Full Text] [Related]  

  • 3. Differences in esophageal cancer treatments.
    Skinner DB
    World J Surg; 1996 May; 20(4):514. PubMed ID: 8669155
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with RO-resected esophageal carcinoma].
    Mühlhöfer A; Kronawitter U; Zoller WG
    Z Gastroenterol; 1998 May; 36(5):479-81. PubMed ID: 9654711
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
    Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preoperative neoadjuvant chemotherapy in esophago-cardial adenocarcinoma?].
    Geissler M
    Dtsch Med Wochenschr; 2006 Jun; 131(23):1344. PubMed ID: 16761207
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of lymphadenectomy in esophageal cancer.
    Darling G
    J Surg Oncol; 2009 Mar; 99(4):189-93. PubMed ID: 19101951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the size of cancer nests in metastatic lymph nodes in human esophageal cancers.
    Komori T; Doki Y; Kabuto T; Ishikawa O; Hiratsuka M; Sasaki Y; Ohigashi H; Murata K; Yamada T; Miyashiro I; Mano M; Ishiguro S; Imaoka S
    J Surg Oncol; 2003 Jan; 82(1):19-27. PubMed ID: 12501165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current theraphy of oesophageal cancer].
    Baumhoer D; Ramadori G
    Z Gastroenterol; 2004 Feb; 42(2):171-4. PubMed ID: 14963791
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment for M1a cancer of the esophagus may not be largely palliative.
    Schomas DA; Miller RC; Quevedo JF
    J Thorac Oncol; 2010 Feb; 5(2):284; author reply 284-5. PubMed ID: 20101155
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma.
    Tachibana M; Kinugasa S; Hirahara N; Yoshimura H
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):427-31. PubMed ID: 18502142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of esophageal cancer].
    Isono K; Koide Y
    Gan No Rinsho; 1989 Jan; Spec No():203-11. PubMed ID: 2915475
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic relevance of lymph node size after 2-field lymph node excision in esophagus carcinomas].
    Schröder W; Baldus SE; Mönig S; Zirbes TK; Dienes HP; Hölscher AH
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):501-3. PubMed ID: 14518306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Esophageal carcinoma: guidelines in surgical therapy].
    Kremer B; Marxsen J; Grimm H; Stoffregen C; Schmid A; Henne-Bruns D
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():284-9. PubMed ID: 9931626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
    Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
    Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of preoperative radiation therapy on the results of the combined treatment of esophageal cancer].
    Mamontov AS; Kukharenko VM; Zimina ES; Dostanova TK
    Med Radiol (Mosk); 1991; 36(11):26-30. PubMed ID: 1943565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status.
    Leers JM; Ayazi S; Hagen JA; Terterov S; Klipfel N; Oezcelik A; Abate E; Lipham JC; DeMeester SR; Banki F; DeMeester TR
    J Am Coll Surg; 2009 Apr; 208(4):553-6. PubMed ID: 19476789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
    Mariette C; Piessen G; Briez N; Triboulet JP
    Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer.
    Tachibana M; Tabara H; Kotoh T; Kinugasa S; Dhar DK; Hishikawa Y; Masunaga R; Kubota H; Nagasue N
    Am J Gastroenterol; 1999 Mar; 94(3):757-65. PubMed ID: 10086663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
    Imdahl A; Schöffel U; Ruf G; Hopf UT
    Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.